SHS Gesellschaft für Beteiligungsmanagement is an independent venture capital firm investing in late-stage medical technology companies. Reinhilde Spatscheck and Dr Bernhard Schirmers founded the company in 1993. Its private equity investments range between €2 million to €20 million per deal. The company focuses on companies involved in Medtech, life sciences, biotechnology, diagnosis, pharmaceutical and digital health. The company’s geographic interest is on regions that speak the German language like Germany, Austria, Switzerland. As of 2020, the company has made 54 investment with 27 portfolio companies with sixteen successful exits.